key: cord-0939404-islde72s
authors: Leong, K. W.; Law, T. L.; Saiful, A. b. S.; Kang, C. C.; Woo, Y. Y.; Chow, T. S.; Yong, Z. L.
title: Excellent negative predictive value (99.8%) of two rapid molecular COVID-19 tests compared to conventional RT-PCR for SARS-CoV-2 (COVID-19) in 2,011 tests performed in a single centre.
date: 2021-06-21
journal: nan
DOI: 10.1101/2021.06.20.21258392
sha: 6ca2e5be88ec803056e78553f07e0b5a727e7cbb
doc_id: 939404
cord_uid: islde72s

Conventional Reverse Transcription Polymerase Chain Reaction (RT-PCR) remains the gold standard for testing SARS-CoV-2. Since their availability, two rapid molecular COVID-19 tests were performed in parallel with RT-PCR in all urgent and emergency admissions, as the negative predictive value was not yet ascertained. In this study, we present the data of 2011 test results using either ID Now COVID-19 (Abbott) (Abbott ID NOW) or Xpert Xpress SARS-CoV-2 (Cepheid) (GeneXpert) tests comparing to conventional RT-PCR results. The negative predictive value is 99.8%(3 false negatives out of 1,964 tests) using a cut-off CT value of 40. Using a cut-off of RT-PCR CT value of 30 (predicting infectivity), the negative predictive value is reduced to 99.9% (1 out of 1,964 tests). With these results, we feel confident to recommend the immediate use of the rapid PCR tests alone and to use conventional RT-PCR for confirmation testing after.

In our centre, the test is not done in-house leading to delay of results of up to three days. For urgent and 38 emergency admissions, this is not ideal as patients remain in isolation until a negative result is obtained, 39 after which patients would be allowed into general wards. Previous studies of rapid COVID-19 tests 40 reported negative predictive values using rather small sample sizes of less than 500 1,2,3,4,5 . With the 41 relatively small sample sizes, our doctors did not feel confident to proceed with high risk procedures, such CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.20.21258392 doi: medRxiv preprint Two swabs were sent to an off-site laboratory for RT-PCR testing. TaqPath RT-PCR Assays from 50 ThermoFisher were performed according to the manufacturers guidelines 6 . This detects three gene targets:

ORF1ab, S gene and N gene. A CT cut-off value of 40 was used according to our national consensus for 52 positivity.

The third swab was used for rapid COVID-19 testing. The samples were processed within one hour. All CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; 

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.20.21258392 doi: medRxiv preprint rapidly changing situation and emergence of new variants, caution has to be considered in regards to how 150 this would affect test results. We will continue monitoring the tests.

We have recommended to discontinue the use of conventional RT-PCR for routine screening of patients CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.20.21258392 doi: medRxiv preprint Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs

Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution. J

Comparison of SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory 174 diagnosis of COVID-19 in Thailand

Reference: TaqCheckTM SARS-CoV-2 Fast PCR Assay

time, this important pre-analytical variable is further reduced. In many reported series, the rapid molecular